PGNY
Progyny Inc
NASDAQ: PGNY · HEALTHCARE · HEALTHCARE PLANS
$27.35
+1.00% today
Updated 2026-09-11
Market cap
$2.08B
P/E ratio
29.51
P/S ratio
1.59x
EPS (TTM)
$0.92
Dividend yield
—
52W range
$16 – $33
Volume
1.1M
WallStSmart proprietary scores
57
out of 100
Grade: C+
Hold
Investment rating
8.0
Growth
A8.0
Quality
A6.5
Profitability
B5.3
Valuation
C+3/9
Piotroski F-Score
Weak
4.5
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →251 stocks currently score above 75
Price targets
Analyst target
$34.42
+25.85%
12-Month target
$18.09
-33.86%
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy9 Buy2 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 4.47 — safe zone
+ Free cash flow $83.81M — positive
+ Debt/equity 0.06x — low leverage
Risks
- Piotroski 3/9 — weak financial health
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $786.91M | $1.09B | $1.17B | $1.29B | $1.31B |
| Net income | $30.36M | $62.04M | $54.34M | $58.52M | $28.05M |
| EPS | — | — | — | — | $0.92 |
| Free cash flow | $77.15M | $185.17M | $173.70M | $191.78M | $83.81M |
| Profit margin | 3.86% | 5.70% | 4.66% | 4.54% | 6.00% |
Peer comparison
Smart narrative
Progyny Inc trades at $27.35. representing a P/E of 29.51x trailing earnings. Our Smart Value Score of 57/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 4.47, it sits in the safe zone. TTM revenue stands at $1.31B. with profit margins at 6.00%.
Frequently asked questions
What is Progyny Inc's stock price?
Progyny Inc (PGNY) trades at $27.35, on a P/E of 29.5x and a P/S of 1.6x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Progyny Inc overvalued?
Progyny Inc carries a Smart Value Score of 57/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of Progyny Inc (PGNY)?
The 12-month analyst consensus target is $34.42, about 25.9% above the current $27.35. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Progyny Inc's revenue?
Progyny Inc's trailing twelve-month revenue is $1.31B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Progyny Inc's Altman Z-Score is 4.47, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryHEALTHCARE PLANS
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.59x
ROE15.41%
Beta0.99
50D MA$28.93
200D MA$24.12
Shares out0.08B
Float0.07B
Short ratio—
Avg volume1.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—